The 340B Program: A drug discount program

The 340B Drug Pricing Program requires drug manufacturers to provide outpatient drugs to eligible healthcare organizations at significantly reduced prices.

What are the objectives of this program?

Stretch scarce federal healthcare financial resources by providing pricing benefits and additional revenue stream to eligible entities. The resulting savings and revenues are intended to be used to provide more care to vulnerable populations.
Increase patient compliance leading to better patient outcomes.

Eligible Organizations

FQHCs
Children’s Hospitals
Disproportionate Share Hospitals
Ryan White Grantees
Title X Family Planning Clinics
STD Clinics

Learn More About 340B

HRSA Enrollment Status*
- Registered
- Unregistered
Name*
First Last
Organization*
Email*
Phone*
CAPTCHA
Email
This field is for validation purposes and should be left unchanged.